cyclopentanone has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aherne, W; Ashworth, A; Boxall, K; Elliott, R; Jones, K; Linardopoulos, S; Lord, CJ; Rayter, S; Richardson, TB; Rowlands, MG; Travers, J; Workman, P | 1 |
Hsiang, CH; Straus, DS | 1 |
2 other study(ies) available for cyclopentanone and Breast Cancer
Article | Year |
---|---|
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cyclopentanes; Drug Resistance, Neoplasm; Enzyme Inhibitors; Growth Inhibitors; HeLa Cells; Humans; Phosphoprotein Phosphatases; Protein Phosphatase 2C | 2008 |
Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Topics: Animals; Base Sequence; Binding Sites; Blotting, Western; Breast Neoplasms; Cell Cycle; Cyclin D1; Cyclopentanes; Electrophoretic Mobility Shift Assay; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, bcl-1; Humans; Molecular Sequence Data; Promoter Regions, Genetic; Protein Binding; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S Phase; Sequence Deletion; Sequence Homology, Nucleic Acid; Transcription Initiation Site; Tumor Cells, Cultured | 2002 |